Cannassure Therapeutics Stock Last Dividend Paid
| CSURE Stock | 717.00 62.80 8.05% |
Cannassure Therapeutics fundamentals help investors to digest information that contributes to Cannassure Therapeutics' financial success or failures. It also enables traders to predict the movement of Cannassure Stock. The fundamental analysis module provides a way to measure Cannassure Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannassure Therapeutics stock.
Cannassure |
Cannassure Therapeutics Company Last Dividend Paid Analysis
Cannassure Therapeutics' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Cannassure Therapeutics has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Healthcare Providers & Services (which currently averages 0.0) industry. This indicator is about the same for all Israel stocks average (which is currently at 0.0).
Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Cannassure Fundamentals
| Return On Equity | -2.11 | |||
| Return On Asset | -0.52 | |||
| Profit Margin | (1.53) % | |||
| Operating Margin | (1.52) % | |||
| Current Valuation | 56.54 M | |||
| Shares Outstanding | 51.17 M | |||
| Shares Owned By Insiders | 51.49 % | |||
| Shares Owned By Institutions | 1.00 % | |||
| Price To Sales | 0.05 X | |||
| Revenue | 16.32 M | |||
| Gross Profit | (14.17 M) | |||
| EBITDA | (20.64 M) | |||
| Net Income | (28.54 M) | |||
| Book Value Per Share | 0.14 X | |||
| Cash Flow From Operations | (20.82 M) | |||
| Earnings Per Share | (0.31) X | |||
| Number Of Employees | 44 | |||
| Beta | 0.69 | |||
| Market Capitalization | 384.26 K |
About Cannassure Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannassure Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannassure Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannassure Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cannassure Stock Analysis
When running Cannassure Therapeutics' price analysis, check to measure Cannassure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannassure Therapeutics is operating at the current time. Most of Cannassure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cannassure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannassure Therapeutics' price. Additionally, you may evaluate how the addition of Cannassure Therapeutics to your portfolios can decrease your overall portfolio volatility.